Cyclo(RGDyK) b
CAS No. 217099-14-4
Cyclo(RGDyK) b ( )
Catalog No. M30392 CAS No. 217099-14-4
Cyclo(RGDyK) is a potent and selective αVβ3 integrin inhibitor with IC50 of 20 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 873 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameCyclo(RGDyK) b
-
NoteResearch use only, not for human use.
-
Brief DescriptionCyclo(RGDyK) is a potent and selective αVβ3 integrin inhibitor with IC50 of 20 nM.
-
DescriptionCyclo(RGDyK) is a potent and selective αVβ3 integrin inhibitor with IC50 of 20 nM.(In Vitro):Cyclo(RGDyK) (c(RGDyK(SAA)) shows high affinity and selectivity for αVβ3 over αVβ5 (IC50=4000 nM) and αIIbβ3 (IC50=3000 nM).
-
Synonyms
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
RecptorIC50: 20 nM (αVβ3 Integrin), 3000 nM (αIIbβ3 Integrin), 4000 nM (αVβ5 Integrin)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number217099-14-4
-
Formula Weight619.7
-
Molecular FormulaC27H41N9O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Haubner R, et al. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med. 2001 Feb;42(2):326-36.
molnova catalog
related products
-
AJM300
AJM300 (AJM 300, AJM-300) is a novel potent, selective, oraaly available alpha 4 integrin antagonist fortreatment of active ulcerative colitis.
-
BIO1211
BIO1211 (BIO-1211) is a potent, highly specific integrin α4β1 (VLA-4) inhibitor with Kd/IC50 of 20 pM/4 nM for the activated form of α4β1.
-
RGD peptide GRGDNP
RGD peptide (GRGDNP) acts as an inhibitor of integrin-ligand interactions and can induce apoptosis in the absence of signals and integrin-mediated cell clustering.